Status:
COMPLETED
Over-the-counter Medications & COVID-19
Lead Sponsor:
University of Alberta
Conditions:
SARS-CoV-2 Infection
Covid19
Eligibility:
All Genders
Brief Summary
Ibuprofen is one of several common medications implicated in coronavirus disease 2019 (COVID-19) severity. On March 11, the Lancet Respiratory Medicine published a letter stating ibuprofen can increas...
Eligibility Criteria
Inclusion
- Residents of the province of Alberta tested for COVID-19 since March 1, 2020
Exclusion
- Individuals who are currently hospitalized, who died, or who do not have contact information in the COVID-19 test record
Key Trial Info
Start Date :
July 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 27 2022
Estimated Enrollment :
461 Patients enrolled
Trial Details
Trial ID
NCT04500639
Start Date
July 23 2020
End Date
May 27 2022
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada